<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03859115</url>
  </required_header>
  <id_info>
    <org_study_id>TENS_AVR</org_study_id>
    <nct_id>NCT03859115</nct_id>
  </id_info>
  <brief_title>Effects of TENS on Myocardial Protection in Patients Undergoing AVR</brief_title>
  <official_title>Effects of TENS on Myocardial Protection in Patients Undergoing AVR</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing aortic valve replacement are randomized to receive TENS (transcutaneous&#xD;
      electrical nerve stimulation) or sham stimulation at one arm for 30 min under various&#xD;
      anesthetic conditions: no anesthesia (preanesthesia), sevoflurane or propofol anesthesia.&#xD;
      Cardioprotective effects of TENS are compared through Langendorff rat heart perfusion system&#xD;
      using plasma dialysate from patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing aortic valve replacement are randomized to one of six groups:&#xD;
      preanesthesia-TENS (transcutaneous electrical nerve stimulation), preanesthesia-sham,&#xD;
      sevoflurane-TENS, sevoflurane-sham, propofol-TENS, propofol-sham. Patients receive TENS or&#xD;
      sham stimulation (without electrical pulse generation) at one arm for 30 min under no&#xD;
      anesthesia (preanesthesia) or sevoflurane or propofol anesthesia.&#xD;
&#xD;
      In all patients, blood samples are obtained before and after TENS or sham procedure to make&#xD;
      plasma dialysate to perfuse rat hearts subjected to ischemia-reperfusion injury through&#xD;
      Langendorff system.&#xD;
&#xD;
      Cardioprotective effects are determined by comparing infarct sizes of rat hearts perfused&#xD;
      with human plasma dialysate, which reflects cardioprotective effects of TENS in human&#xD;
      subjects. By comparing infarct size differences, the myocardial protective effects of TENS in&#xD;
      various anesthetic conditions can be determined in human subjects undergoing aortic valve&#xD;
      replacement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Actual">January 4, 2021</completion_date>
  <primary_completion_date type="Actual">April 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size after TENS</measure>
    <time_frame>30 minutes</time_frame>
    <description>Infarct size of rat hearts perfused with dialysate after TENS compared with sham</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Myocardial Protection</condition>
  <arm_group>
    <arm_group_label>preanesthesia-TENS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in preanesthesia-TENS group receive TENS for 30 minutes at one arm before anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>preanesthesia-sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients in preanesthesia-sham group receive sham stimulation for 30 minutes at one arm before anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane-TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in sevoflurane-TENS group receive TENS for 30 minutes at one arm under sevoflurane anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane-sham</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in sevoflurane-sham group receive sham stimulation for 30 minutes at one arm under sevoflurane anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol-TENS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in propofol-TENS group receive TENS for 30 minutes at one arm under propofol anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol-sham</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in propofol-sham group receive sham stimulation for 30 minutes at one arm under propofol anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>TENS (transcutaneous electrical nerve stimulation)</intervention_name>
    <description>transcutaneous nerve stimulation with electrical pulse generation</description>
    <arm_group_label>preanesthesia-TENS</arm_group_label>
    <arm_group_label>propofol-TENS</arm_group_label>
    <arm_group_label>sevoflurane-TENS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham intervention</intervention_name>
    <description>sham stimulation without electrical pulse generation</description>
    <arm_group_label>preanesthesia-sham</arm_group_label>
    <arm_group_label>propofol-sham</arm_group_label>
    <arm_group_label>sevoflurane-sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing aortic valve replacement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  co-medications: metformin, nitroglycerine, nicorandil&#xD;
&#xD;
          -  discomfort at TENS or loss of intact skin&#xD;
&#xD;
          -  uncontrolled hypertension or diabetes mellitus&#xD;
&#xD;
          -  severely impaired renal or hepatic function&#xD;
&#xD;
          -  peripheral vasculopathy or neuropathy&#xD;
&#xD;
          -  did not consent to participate&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yunseok Jeon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>February 25, 2019</study_first_submitted>
  <study_first_submitted_qc>February 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2019</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yunseok Jeon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>transcutaneous electrical nerve stimulation</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>propofol</keyword>
  <keyword>anesthesia</keyword>
  <keyword>myocardial protection</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

